Gijs Zom

Gijs Zom

Genmab - Copenhagen / Denmark
Others
AD Scientific Index ID: 4971001
person_outline Gijs Zom's MOST POPULAR ARTICLES
1-) Efficient induction of antitumor immunity by synthetic toll-like receptor ligand–peptide conjugatesGG Zom, S Khan, CM Britten, V Sommandas, MGM Camps, NM Loof, ...Cancer immunology research 2 (8), 756-764, 20141162014
2-) TLR ligand–peptide conjugate vaccines: toward clinical application GGP Zom, S Khan, DV Filippov, F Ossendorp Advances in immunology 114, 177-201, 2012 962012
3-) Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication GG Zom, MM Willems, S Khan, TC van der Sluis, JW Kleinovink, ... Journal for ImmunoTherapy of Cancer 6 (1), 1-13, 2018 592018
4-) TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patientsGG Zom, MJP Welters, NM Loof, R Goedemans, S Lougheed, ...Oncotarget 7 (41), 67087, 2016632016
5-) N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2MM Willems, GG Zom, S Khan, N Meeuwenoord, CJM Melief, ...Journal of medicinal chemistry 57 (15), 6873-6878, 2014502014